How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?

Andrew J Vickers; Giorgio Russo; Hans Lilja; Christopher Evans; Jack A Schalken; Eric Klein; Scott Eggener

doi:10.1016/j.euo.2021.01.010

How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?

Andrew J Vickers, Giorgio Russo, Hans Lilja, Christopher Evans, Jack A Schalken, Eric Klein, Scott Eggener

Research output: Contribution to journal › Debate/Note/Editorial › peer-review

Abstract

The literature gives limited data or guidance on how to select or combine biomarkers and magnetic resonance imaging (MRI) for the early detection of prostate cancer. We strongly recommend prospective studies large enough to address questions such as the properties of biomarkers in cases with high versus low Prostate Imaging-Reporting and Data System scores or the correlation between biomarkers and MRI, and that evaluate results in the context of reasonable clinical scenarios.

Original language	English
Pages (from-to)	135-137
Number of pages	3
Journal	European Urology Oncology
Volume	5
Issue number	2
DOIs	https://doi.org/10.1016/j.euo.2021.01.010
Publication status	Published - 2022 Apr
Externally published	Yes

Subject classification (UKÄ)

Cancer and Oncology

Free keywords

Biomarkers
Early Detection of Cancer
Humans
Image-Guided Biopsy/methods
Magnetic Resonance Imaging/methods
Male
Prospective Studies
Prostatic Neoplasms/diagnostic imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.euo.2021.01.010

Cite this

@article{f9d1386433c749aa946354c3b18249a3,

title = "How Should Molecular Markers and Magnetic Resonance Imaging Be Used in the Early Detection of Prostate Cancer?",

abstract = "The literature gives limited data or guidance on how to select or combine biomarkers and magnetic resonance imaging (MRI) for the early detection of prostate cancer. We strongly recommend prospective studies large enough to address questions such as the properties of biomarkers in cases with high versus low Prostate Imaging-Reporting and Data System scores or the correlation between biomarkers and MRI, and that evaluate results in the context of reasonable clinical scenarios.",

keywords = "Biomarkers, Early Detection of Cancer, Humans, Image-Guided Biopsy/methods, Magnetic Resonance Imaging/methods, Male, Prospective Studies, Prostatic Neoplasms/diagnostic imaging",

author = "Vickers, {Andrew J} and Giorgio Russo and Hans Lilja and Christopher Evans and Schalken, {Jack A} and Eric Klein and Scott Eggener",

year = "2022",

month = apr,

doi = "10.1016/j.euo.2021.01.010",

language = "English",

volume = "5",

pages = "135--137",

journal = "European Urology Oncology",

issn = "2588-9311",